Daniël Kleinloog

638 total citations
12 papers, 486 citations indexed

About

Daniël Kleinloog is a scholar working on Pharmacology, Clinical Psychology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daniël Kleinloog has authored 12 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Clinical Psychology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daniël Kleinloog's work include Cannabis and Cannabinoid Research (7 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Psychedelics and Drug Studies (4 papers). Daniël Kleinloog is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Psychedelics and Drug Studies (4 papers). Daniël Kleinloog collaborates with scholars based in Netherlands, United States and Italy. Daniël Kleinloog's co-authors include Joop van Gerven, Linda E. Klumpers, Monica Airoldi, Veronica Ravasio, Franco Maggiolo, Annapaola Callegaro, Claudio Arici, Enrico Bombana, Fredy Suter and Marieke L. de Kam and has published in prestigious journals such as Critical Care, Psychiatry Research and British Journal of Clinical Pharmacology.

In The Last Decade

Daniël Kleinloog

12 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniël Kleinloog Netherlands 8 300 122 114 69 58 12 486
Will Toperoff United States 4 274 0.9× 63 0.5× 66 0.6× 73 1.1× 28 0.5× 4 426
Haatem Reda United States 10 396 1.3× 41 0.3× 105 0.9× 24 0.3× 34 0.6× 22 651
Paul Bellman United States 4 371 1.2× 43 0.4× 122 1.1× 35 0.5× 36 0.6× 5 552
Barbara Broers Switzerland 9 79 0.3× 107 0.9× 33 0.3× 40 0.6× 22 0.4× 20 352
Krista J. Siefried Australia 12 60 0.2× 164 1.3× 107 0.9× 113 1.6× 67 1.2× 45 537
Alfio Lucchini Italy 10 50 0.2× 60 0.5× 78 0.7× 41 0.6× 47 0.8× 20 370
Paul Casadonte United States 10 249 0.8× 78 0.6× 254 2.2× 15 0.2× 68 1.2× 13 1.4k
Norbert Loimer Austria 14 97 0.3× 27 0.2× 100 0.9× 25 0.4× 64 1.1× 29 554
K Tunving Sweden 11 148 0.5× 43 0.4× 90 0.8× 15 0.2× 76 1.3× 18 455
Yiyang Liu United States 8 51 0.2× 45 0.4× 58 0.5× 9 0.1× 29 0.5× 39 365

Countries citing papers authored by Daniël Kleinloog

Since Specialization
Citations

This map shows the geographic impact of Daniël Kleinloog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniël Kleinloog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniël Kleinloog more than expected).

Fields of papers citing papers by Daniël Kleinloog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniël Kleinloog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniël Kleinloog. The network helps show where Daniël Kleinloog may publish in the future.

Co-authorship network of co-authors of Daniël Kleinloog

This figure shows the co-authorship network connecting the top 25 collaborators of Daniël Kleinloog. A scholar is included among the top collaborators of Daniël Kleinloog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniël Kleinloog. Daniël Kleinloog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kleinloog, Daniël. (2024). Ketamine-Assisted Psychotherapy: opportunities and challenges. Medical Research Archives. 1 indexed citations
2.
Hindley, Guy, Katherine Beck, Faith Borgan, et al.. (2020). Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet Psychiatry. 7(4). 344–353. 131 indexed citations
3.
Kleinloog, Daniël, Serge A.R.B. Rombouts, Linda E. Klumpers, et al.. (2015). Subjective Effects of Ethanol, Morphine, Δ 9 -Tetrahydrocannabinol, and Ketamine Following a Pharmacological Challenge Are Related to Functional Brain Connectivity. Brain Connectivity. 5(10). 641–648. 13 indexed citations
4.
Kleinloog, Daniël, Albert Dahan, René Mooren, et al.. (2015). Optimizing the glutamatergic challenge model for psychosis, using S(+)-ketamine to induce psychomimetic symptoms in healthy volunteers. Journal of Psychopharmacology. 29(4). 401–413. 14 indexed citations
5.
Kleinloog, Daniël, et al.. (2015). Triage after drug overdose: effect of the Introduction of a medical psychiatry unit on the allocation of ICU beds. Critical Care. 19(S1). 1 indexed citations
6.
Kleinloog, Daniël, Jasper Stevens, Jules A. A. C. Heuberger, Philip Spinhoven, & Joop van Gerven. (2014). The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol. Psychiatry Research. 220(3). 945–953. 3 indexed citations
7.
Kleinloog, Daniël, et al.. (2014). Profiling the subjective effects of Δ9‐tetrahydrocannabinol using visual analogue scales. International Journal of Methods in Psychiatric Research. 23(2). 245–256. 18 indexed citations
8.
Klumpers, Linda E., Marieke L. de Kam, Paul B. Little, et al.. (2013). Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects. British Journal of Clinical Pharmacology. 76(6). 846–857. 67 indexed citations
9.
Klumpers, Linda E., Tim L. Beumer, J. G. Coen van Hasselt, et al.. (2012). Novel Δ9‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects. British Journal of Clinical Pharmacology. 74(1). 42–53. 64 indexed citations
10.
Kleinloog, Daniël, Gabriël E. Jacobs, Erica S. Klaassen, et al.. (2012). Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol?. Journal of Psychopharmacology. 26(10). 1307–1316. 42 indexed citations
11.
Klumpers, Linda E., Tim L. Beumer, J. G. Coen van Hasselt, et al.. (2011). Novel Δ9-tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects. British Journal of Clinical Pharmacology. no–no. 3 indexed citations
12.
Maggiolo, Franco, Monica Airoldi, Daniël Kleinloog, et al.. (2007). Effect of Adherence to HAART on Virologic Outcome and on the Selection of Resistance-Conferring Mutations in NNRTI- or PI-Treated Patients. HIV Clinical Trials. 8(5). 282–292. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Will Toperoff Breakdown of academic impact, for papers by Haatem Reda Breakdown of academic impact, for papers by Paul Bellman Breakdown of academic impact, for papers by Barbara Broers Breakdown of academic impact, for papers by Krista J. Siefried Breakdown of academic impact, for papers by Alfio Lucchini Breakdown of academic impact, for papers by Paul Casadonte Breakdown of academic impact, for papers by Norbert Loimer Breakdown of academic impact, for papers by K Tunving Breakdown of academic impact, for papers by Yiyang Liu
Rankless by CCL
2026